GPX4 and hepatocellular carcinoma: GA, a novel HC ferroptosis inducer, inactivates the Wnt/β‐catenin pathway in HepG2 cells, limiting the production of ferroptosis‐related proteins SLC7A11 and GPX4, potentially promising for the clinical management of HCC [117].